CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Gene expression signatures can predict the efficacy of anthracyclines in HER2-negative and HER2-positive breast cancer (BC) patients: The results of the TOP trial and their validation in the BIG1-00 trial.
Authors
Evandro Azambuja
Veronique D'Hondt
+8 more
Suzette Delaloge
Christine Desmedt
Angelo Di Leo
Caroline Duhem
Benjamin Haibe-Kains
Denis Larsimont
Martine Piccart-Gebhart
Christos Sotiriou
Publication date
1 April 2009
Publisher
Abstract
Abstract 1250info:eu-repo/semantics/publishe
Similar works
Full text
Available Versions
DI-fusion
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dipot.ulb.ac.be:2013/24471...
Last time updated on 23/02/2017
DI-fusion
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dipot.ulb.ac.be:2013/15476...
Last time updated on 03/03/2014
DI-fusion
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dipot.ulb.ac.be:2013/24471...
Last time updated on 23/02/2017
